These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19302897)

  • 41. Low density lipoprotein cholesterol, statins and cardiovascular events: a meta-analysis.
    Genser B; März W
    Clin Res Cardiol; 2006 Aug; 95(8):393-404. PubMed ID: 16773275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
    ; Mihaylova B; Emberson J; Blackwell L; Keech A; Simes J; Barnes EH; Voysey M; Gray A; Collins R; Baigent C
    Lancet; 2012 Aug; 380(9841):581-90. PubMed ID: 22607822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants.
    Wang N; Fulcher J; Abeysuriya N; Park L; Kumar S; Di Tanna GL; Wilcox I; Keech A; Rodgers A; Lal S
    Lancet Diabetes Endocrinol; 2020 Jan; 8(1):36-49. PubMed ID: 31862150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials.
    Naci H; Brugts JJ; Fleurence R; Tsoi B; Toor H; Ades AE
    Eur J Prev Cardiol; 2013 Aug; 20(4):641-57. PubMed ID: 23447425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention.
    Amarenco P; Labreuche J
    Lancet Neurol; 2009 May; 8(5):453-63. PubMed ID: 19375663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
    Baigent C; Keech A; Kearney PM; Blackwell L; Buck G; Pollicino C; Kirby A; Sourjina T; Peto R; Collins R; Simes R;
    Lancet; 2005 Oct; 366(9493):1267-78. PubMed ID: 16214597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.
    Hebert PR; Gaziano JM; Chan KS; Hennekens CH
    JAMA; 1997 Jul 23-30; 278(4):313-21. PubMed ID: 9228438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis.
    Byrne P; Demasi M; Jones M; Smith SM; O'Brien KK; DuBroff R
    JAMA Intern Med; 2022 May; 182(5):474-481. PubMed ID: 35285850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.
    Vrecer M; Turk S; Drinovec J; Mrhar A
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):567-77. PubMed ID: 14692706
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants.
    Yebyo HG; Aschmann HE; Kaufmann M; Puhan MA
    Am Heart J; 2019 Apr; 210():18-28. PubMed ID: 30716508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials.
    Thavendiranathan P; Bagai A; Brookhart MA; Choudhry NK
    Arch Intern Med; 2006 Nov; 166(21):2307-13. PubMed ID: 17130382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis.
    Wang N; Woodward M; Huffman MD; Rodgers A
    Circ Cardiovasc Qual Outcomes; 2022 Jun; 15(6):e008552. PubMed ID: 35430872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interpretation of the evidence for the efficacy and safety of statin therapy.
    Collins R; Reith C; Emberson J; Armitage J; Baigent C; Blackwell L; Blumenthal R; Danesh J; Smith GD; DeMets D; Evans S; Law M; MacMahon S; Martin S; Neal B; Poulter N; Preiss D; Ridker P; Roberts I; Rodgers A; Sandercock P; Schulz K; Sever P; Simes J; Smeeth L; Wald N; Yusuf S; Peto R
    Lancet; 2016 Nov; 388(10059):2532-2561. PubMed ID: 27616593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term efficacy and safety of statin treatment beyond six years: a meta-analysis of randomized controlled trials with extended follow-up.
    Lv HL; Jin DM; Liu M; Liu YM; Wang JF; Geng DF
    Pharmacol Res; 2014 Mar; 81():64-73. PubMed ID: 24602799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials.
    Zaccardi F; Kunutsor SK; Seidu S; Davies MJ; Khunti K
    Atherosclerosis; 2018 Apr; 271():223-231. PubMed ID: 29524865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduction of C-reactive protein is not associated with reduced cardiovascular risk and mortality in patients treated with statins. A meta-analysis of 22 randomized trials.
    Savarese G; Rosano GM; Parente A; D'Amore C; Reiner MF; Camici GG; Trimarco B; Perrone-Filardi P
    Int J Cardiol; 2014 Nov; 177(1):152-60. PubMed ID: 25499365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.
    LaRosa JC; He J; Vupputuri S
    JAMA; 1999 Dec 22-29; 282(24):2340-6. PubMed ID: 10612322
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment with statins: lowering of cholesterol or more?].
    Rutishauser J
    Praxis (Bern 1994); 2006 Jan; 95(4):107-10. PubMed ID: 16485605
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.
    ; Fulcher J; O'Connell R; Voysey M; Emberson J; Blackwell L; Mihaylova B; Simes J; Collins R; Kirby A; Colhoun H; Braunwald E; La Rosa J; Pedersen TR; Tonkin A; Davis B; Sleight P; Franzosi MG; Baigent C; Keech A
    Lancet; 2015 Apr; 385(9976):1397-405. PubMed ID: 25579834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modeling Statin-Induced Reductions of Cardiovascular Events in Primary Prevention: A VOYAGER Meta-Analysis.
    Karlson BW; Nicholls SJ; Lundman P; Barter PJ; Palmer MK
    Cardiology; 2018; 140(1):30-34. PubMed ID: 29705799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.